查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1874594

全球掌性层析管柱市场

Chiral Chromatography Column
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球掌性层析管柱市场预计到2030年将达到1.507亿美元

全球掌性层析管柱市场预计在2024年达到1.21亿美元，预计2030年将达到1.507亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为3.7%。本报告分析的细分市场之一「製药和生物技术应用」预计将以4.2%的复合年增长率成长，并在分析期结束时达到5,420万美元。同时，「实验室」细分市场预计在分析期间内将以2.4%的复合年增长率成长。

美国市场规模估计为3,220万美元，而中国市场预计将以3.6%的复合年增长率成长。

预计2024年，美国掌性层析管柱市场规模将达3,220万美元。作为世界第二大经济体，中国市场预计到2030年将达到2,410万美元，在2024年至2030年的分析期间内，年复合成长率（CAGR）为3.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的年复合成长率分别为3.5%和3.1%。在欧洲，德国的年复合成长率预计约为3.6%。

全球掌性层析管柱市场—主要趋势与驱动因素概述

为什么掌性层析管柱在现代分析化学中如此重要？

掌性层析管柱已成为现代分析化学中不可或缺的工具，尤其是在製药、农业化学品和食品生产等产业。掌性层析法用于分离对映异构体，这些分子互为镜像且不可重迭。这些对映异构体通常表现出不同的生物活性，其中一种可能具有潜在的益处，而另一种则无效甚至有害。这在药物研发中尤其重要，因为准确分离和鑑定对映异构体对于确保药物的安全性和有效性至关重要。因此，掌性层析管柱能够选择性地分离和分析这些对映异构体，使其成为品管和研究的必备工具。此外，美国食品药物管理局（FDA）等监管机构要求许多药品必须证明其对映体纯度，这进一步凸显了掌性层析法在满足安全标准方面的重要性。

掌性层析法如何满足您复杂的分子分离需求？

高效分离复杂分子混合物的能力是各行各业的关键需求，而掌性层析管柱尤其适合满足这些需求。掌性层析法的有效性在于其色谱管柱内特化的固定相。这些固定相的设计使其能够与化合物的每个对映异构体产生不同的相互作用，选择性地保留一种对映异构体，同时允许另一种对映异构体通过。这种选择性相互作用使得难以用传统层析法技术区分的掌性化合物得以分离。掌性层析管柱可采用多种固定相材料，包括多醣、蛋白质或大环糖肽基材料，每种材料都针对不同掌性分子的特定分离需求而设计。这种多功能性使研究人员能够根据目标分析物的化学性质定制色谱柱，以实现对映异构体的最佳分离。此外，色谱管技术的进步使得即使在含有多个掌性中心的复杂混合物中，也能实现更快、更精确的分离。这种能力在製药和农业化学品等行业中至关重要，因为在这些行业中，精确的对映体分离对于产品开发、安全性和法规遵循至关重要。

哪些技术进步将塑造掌性层析管柱的未来？

技术创新不断突破掌性层析管柱的界限，提升其效率、精密度和通用性。其中一项关键进展是超高效液相层析法（UHPLC）系统的引进。 UHPLC系统越来越多地与手性色谱柱联用，以实现更快、更高分辨率的分离。 UHPLC允许在色谱柱内施加更高的压力并使用更细的颗粒，从而提高分离效率。这项技术在製药业尤其重要，因为更短的分析时间可以显着加快药物研发进程。另一项重要的创新在于固定相材料的改良。近期的进展促成了更具选择性和更耐用的固定相的开发，这些固定相能够承受更广泛的化学条件。例如，掌性分离中最常用的多醣基色谱柱展现出更高的化学稳定性和使用寿命，使其能够在更严苛的条件下使用而不会劣化。此外，固定掌性选择剂的进步也拓展了可用于掌性分离的溶剂范围，为研究人员和生产商提供了更大的灵活性。这在需要绿色化学解决方案的行业中尤其重要，因为使用环保溶剂正成为重中之重。这些技术进步不仅提高了掌性层析管柱的性能，还拓展了其在更广泛的工业和科学领域的应用。

掌性层析管柱市场的主要成长要素是什么？

掌性层析管柱市场的成长受多种因素驱动，包括药物研发的进步、日益严格的监管要求以及分离技术的创新。其中一个关键驱动因素是不断扩张的製药业，尤其是对光学纯药物日益增长的需求。随着药物研发的推进，对精确分离对映体的需求不断增长，特别是对于那些具有掌性中心且可能具有不同生物效应的化合物。这促使掌性层析管柱迅速成为确保药物安全性和有效性的关键工具。此外，药物开发平臺中生物製药和复杂小分子药物数量的增加，进一步推动了对先进分离技术的需求，并凸显了掌性层析法在药物研发中的重要性。监管压力也是一个重要的成长要素，例如FDA和EMA等机构要求製药公司证明其产品的对映体纯度。这种监管环境使得掌性层析法成为品管和合规性的关键工具，从而推动了色谱柱应用的扩展。此外，超高效液相层析（UHPLC）技术的进步和高选择性固定相的开发，使得掌性层析法速度更快、效率更高、应用范围更广，从而促进了其在包括农药、香精香料等在内的众多领域的应用。最后，人们对永续性和绿色化学的日益关注，正推动企业采用能够使用环保溶剂和製程的新型色谱柱技术。这些趋势，加上各行业对精度、合规性和创新性的需求，预计将持续推动对高性能掌性层析管柱的需求。

部分：

依最终用途（製药和生物技术、实验室、医院、食品和饮料、其他最终用途）

受访公司范例

  • Agilent Technologies, Inc.
  • Daicel Corporation
  • GE Healthcare
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • Regis Technologies, Inc.
  • Repligen Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Biosciences LLC
  • VWR International LLC
  • WR Grace & Co.
  • Waters Corporation
  • ZirChrom Separations, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，变革市场和竞争情报分析。

Global Industry Analysts 并没有依赖通用的 LLM 或查询产业专用的SLM，而是建立了一个由世界各地领域专家精心整理的内容库，包括视讯转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对区域市场的影响，正如全球产业分析师预测的那样，关税将改变企业的竞争地位，而企业的竞争地位将取决于其总部所在地、製造地以及进出口（成品和OEM产品）。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP11017

Global Chiral Chromatography Column Market to Reach US$150.7 Million by 2030

The global market for Chiral Chromatography Column estimated at US$121.0 Million in the year 2024, is expected to reach US$150.7 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Pharmaceutical & Biotechnology End-Use, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$54.2 Million by the end of the analysis period. Growth in the Research Laboratories End-Use segment is estimated at 2.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.2 Million While China is Forecast to Grow at 3.6% CAGR

The Chiral Chromatography Column market in the U.S. is estimated at US$32.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$24.1 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Chiral Chromatography Column Market - Key Trends and Drivers Summarized

Why Are Chiral Chromatography Columns Crucial in Modern Analytical Chemistry?

Chiral chromatography columns have become indispensable tools in modern analytical chemistry, particularly in industries such as pharmaceuticals, agrochemicals, and food production. Chiral chromatography is used to separate enantiomers, which are molecules that are mirror images of each other but cannot be superimposed. These enantiomers often exhibit different biological activities, meaning one may be beneficial while the other could be ineffective or even harmful. This is especially critical in pharmaceutical development, where precise separation and identification of enantiomers are necessary to ensure the safety and efficacy of drugs. Chiral chromatography columns, therefore, provide the ability to selectively separate and analyze these enantiomers, making them essential for quality control and research. Moreover, regulatory authorities, such as the FDA, mandate that enantiomeric purity be demonstrated in many drug products, further emphasizing the importance of chiral chromatography in compliance with safety standards.

How Does Chiral Chromatography Meet the Needs of Complex Molecular Separations?

The ability to separate complex molecular mixtures efficiently has become a critical need across various industries, and chiral chromatography columns are uniquely suited to meet these demands. The effectiveness of chiral chromatography lies in the specialized stationary phases within the columns. These phases are designed to interact differently with each enantiomer of a compound, allowing for the selective retention of one enantiomer while the other passes through. This differential interaction is what enables the separation of chiral compounds, which would otherwise be indistinguishable using traditional chromatography techniques. Chiral chromatography columns are available with various stationary phase materials, such as polysaccharide-based, protein-based, or macrocyclic glycopeptide-based phases, each tailored to the specific separation needs of different chiral molecules. This versatility allows researchers to customize the column for the best resolution of enantiomers based on the chemical properties of the sample being analyzed. Furthermore, advancements in column technology have made it possible to achieve these separations more rapidly and with higher precision, even in complex mixtures containing multiple chiral centers. This capability is crucial for industries like pharmaceuticals and agrochemicals, where accurate enantiomeric separation is necessary for product development, safety, and compliance with regulatory standards.

What Technological Advancements Are Shaping the Future of Chiral Chromatography Columns?

Technological innovations continue to push the boundaries of what chiral chromatography columns can achieve, enhancing their efficiency, accuracy, and versatility. One major development is the introduction of ultra-high-performance liquid chromatography (UHPLC) systems, which are increasingly used with chiral columns to achieve faster separations with higher resolution. UHPLC allows for greater pressure and smaller particle sizes in the column, resulting in more efficient separations. This technology is particularly beneficial in industries like pharmaceuticals, where faster analysis times can significantly speed up the drug development process. Another important innovation is in the materials used for the stationary phases. Recent advancements have led to the creation of more selective and durable stationary phases that can withstand a broader range of chemical conditions. For example, polysaccharide-based columns, which are among the most commonly used for chiral separations, have seen improvements in their chemical stability and longevity, allowing them to be used under more aggressive conditions without degradation. Furthermore, advances in immobilized chiral selectors have expanded the range of solvents that can be used in chiral separations, providing greater flexibility for researchers and manufacturers. This is particularly relevant in industries that require green chemistry solutions, where the ability to use environmentally friendly solvents is becoming a priority. These technological advancements are not only improving the performance of chiral chromatography columns but are also expanding their applicability across a wider range of industries and scientific disciplines.

What Are the Key Growth Drivers of the Chiral Chromatography Columns Market?

The growth in the chiral chromatography columns market is driven by several factors, including advancements in pharmaceutical research, increasing regulatory requirements, and technological innovations in separation techniques. One of the primary drivers is the expanding pharmaceutical industry, particularly the growing demand for enantiomerically pure drugs. As drug development continues to advance, there is an increasing need for precise enantiomeric separation, especially for compounds with chiral centers that may have different biological effects. This has led to a surge in the adoption of chiral chromatography columns as a critical tool for ensuring drug safety and efficacy. Additionally, the rise in biologics and complex small molecules in the pharmaceutical pipeline has further driven demand for advanced separation techniques, reinforcing the importance of chiral chromatography in drug development. Regulatory pressure is another significant growth driver, as agencies like the FDA and EMA require that pharmaceutical companies demonstrate the enantiomeric purity of their products. This regulatory landscape has made chiral chromatography essential for quality control and regulatory compliance, spurring greater adoption of these columns. Moreover, advancements in UHPLC and more selective stationary phases have made chiral chromatography faster, more efficient, and more accessible, encouraging its use across a broader range of applications, including agrochemicals, flavors, and fragrances. Finally, the growing focus on sustainability and green chemistry is pushing companies to adopt new column technologies that allow for environmentally friendly solvents and processes. As these trends converge, the demand for high-performance chiral chromatography columns is expected to continue rising, driven by the need for precision, compliance, and innovation in various industries.

SCOPE OF STUDY:

The report analyzes the Chiral Chromatography Column market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 13 Featured) -

  • Agilent Technologies, Inc.
  • Daicel Corporation
  • GE Healthcare
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Phenomenex, Inc.
  • Regis Technologies, Inc.
  • Repligen Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Biosciences LLC
  • VWR International LLC
  • W. R. Grace & Co.
  • Waters Corporation
  • ZirChrom Separations, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Chiral Chromatography Column - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Enantiomeric Purity in Pharmaceuticals Propels Growth in the Chiral Chromatography Column Market
    • Advancements in Drug Discovery Strengthen the Business Case for High-Performance Chiral Chromatography Columns
    • Growing Demand for Biopharmaceuticals Throws Spotlight on High-Resolution Chiral Chromatography Technologies
    • Advancements in Chromatographic Materials Spur Growth in Efficient Chiral Separation Processes
    • Expansion of the Agrochemical Industry Generates New Opportunities for Chiral Chromatography in Pesticide Development
    • Increasing Use of Chiral Chromatography in Food and Beverage Testing Expands Market Applications
    • Innovation in High-Pressure Liquid Chromatography (HPLC) Drives Adoption of Chiral Chromatography Columns
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Chiral Chromatography Column Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Chiral Chromatography Column by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Chiral Chromatography Column by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Chiral Chromatography Column by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharmaceutical & Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Food & Beverage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Chiral Chromatography Column by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Chiral Chromatography Column by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Chiral Chromatography Column by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Chiral Chromatography Column Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Chiral Chromatography Column by End-Use - Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of World 15-Year Perspective for Chiral Chromatography Column by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Research Laboratories, Hospitals, Food & Beverage and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION